Market Cap 3.60B
Revenue (ttm) 0.00
Net Income (ttm) -246.29M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.21
Volume 2,344,000
Avg Vol 2,178,780
Day's Range N/A - N/A
Shares Out 96.13M
Stochastic %K 99%
Beta 0.42
Analysts Strong Sell
Price Target $47.80

Company Profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFß) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively targ...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 259 3860
Address:
301 Binney Street, 3rd Floor, Cambridge, United States
oreoPp
oreoPp Oct. 7 at 2:59 AM
$TECX So it can be. Like. Phase 3 validation. TX45 phase 1b part b + AZD 3427 phase 2b. Combo. $SRRK Stars ⭐️ need to align Plus market sentiment and biotechs. perking up recently. + short int at 22%. + Springer to. Buy more. Could be. Explosive. 🧨
0 · Reply
oreoPp
oreoPp Oct. 7 at 2:47 AM
$TECX $SRRK If Tim Springer and Alise repeat again. It’s 10x given the suppressed market cap. $0 EV
0 · Reply
Sillyspuh
Sillyspuh Oct. 6 at 7:59 PM
$SRRK Nice recovery
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 5 at 3:41 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SRRK Current Share Price: $37.47 Contracts: $SRRK January 15, 2027 $40 Calls Scale in: $8.61- $10.53 Scale out: $13.40-$17.23 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 4 at 6:00 PM
$SRRK $SMLR $IMAB $BTAI Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 4 at 5:47 PM
$SRRK $TONX $INTS $GVH Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 7:55 AM
$SRRK: Unusual Options Activity Alerted CALL flow observed 42x contracts at Strike price of $30 Exp on 10/17/2025 with Premium of $28K and showing BEARISH Sentiment
0 · Reply
cheating_stock_investor
cheating_stock_investor Oct. 3 at 3:00 PM
$SRRK completely dead board. Well i am still here.
0 · Reply
SweepCastApp
SweepCastApp Oct. 1 at 10:25 PM
$SRRK: Unusual Options Activity Alerted CALL flow observed 25x contracts at Strike price of $30 Exp on 01/16/2026 with Premium of $27K and showing NEUTRAL Sentiment
0 · Reply
cheating_stock_investor
cheating_stock_investor Oct. 1 at 2:08 PM
$SRRK funny i was just reading this seekingalpha article about why they got rejected and noticed the reason the manufacuring site failed was due to cat hairs found in the should be sterile environment. Almost like some guys at $NVO who owns the failed facility sabotaged it on purpose so they can own it. Of course we all know novo has a blockbuster drug that combines well with a drug scholar rock is testing out. https://seekingalpha.com/article/4825260?gt=f7616ae03966524e This situation thus places srrk in a place where we know it has value to multiple parties. At this stage approval or not this is going higher.
0 · Reply
Latest News on SRRK
US FDA declines to approve Scholar Rock's muscle weakness drug

Sep 23, 2025, 7:12 AM EDT - 13 days ago

US FDA declines to approve Scholar Rock's muscle weakness drug


Scholar Rock's drug helps preserve lean mass in mid-stage trial

Jun 18, 2025, 7:12 AM EDT - 3 months ago

Scholar Rock's drug helps preserve lean mass in mid-stage trial


Scholar Rock to Participate in Upcoming Investor Conferences

Feb 25, 2025, 4:15 PM EST - 7 months ago

Scholar Rock to Participate in Upcoming Investor Conferences


Scholar Rock Highlights 2025 Strategic Priorities

Jan 8, 2025, 4:00 PM EST - 9 months ago

Scholar Rock Highlights 2025 Strategic Priorities


Scholar Rock (SRRK) Shares Surge on Successful SMA Drug Trial

Oct 7, 2024, 10:10 PM EDT - 1 year ago

Scholar Rock (SRRK) Shares Surge on Successful SMA Drug Trial


oreoPp
oreoPp Oct. 7 at 2:59 AM
$TECX So it can be. Like. Phase 3 validation. TX45 phase 1b part b + AZD 3427 phase 2b. Combo. $SRRK Stars ⭐️ need to align Plus market sentiment and biotechs. perking up recently. + short int at 22%. + Springer to. Buy more. Could be. Explosive. 🧨
0 · Reply
oreoPp
oreoPp Oct. 7 at 2:47 AM
$TECX $SRRK If Tim Springer and Alise repeat again. It’s 10x given the suppressed market cap. $0 EV
0 · Reply
Sillyspuh
Sillyspuh Oct. 6 at 7:59 PM
$SRRK Nice recovery
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 5 at 3:41 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SRRK Current Share Price: $37.47 Contracts: $SRRK January 15, 2027 $40 Calls Scale in: $8.61- $10.53 Scale out: $13.40-$17.23 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 4 at 6:00 PM
$SRRK $SMLR $IMAB $BTAI Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve.
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 4 at 5:47 PM
$SRRK $TONX $INTS $GVH Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 7:55 AM
$SRRK: Unusual Options Activity Alerted CALL flow observed 42x contracts at Strike price of $30 Exp on 10/17/2025 with Premium of $28K and showing BEARISH Sentiment
0 · Reply
cheating_stock_investor
cheating_stock_investor Oct. 3 at 3:00 PM
$SRRK completely dead board. Well i am still here.
0 · Reply
SweepCastApp
SweepCastApp Oct. 1 at 10:25 PM
$SRRK: Unusual Options Activity Alerted CALL flow observed 25x contracts at Strike price of $30 Exp on 01/16/2026 with Premium of $27K and showing NEUTRAL Sentiment
0 · Reply
cheating_stock_investor
cheating_stock_investor Oct. 1 at 2:08 PM
$SRRK funny i was just reading this seekingalpha article about why they got rejected and noticed the reason the manufacuring site failed was due to cat hairs found in the should be sterile environment. Almost like some guys at $NVO who owns the failed facility sabotaged it on purpose so they can own it. Of course we all know novo has a blockbuster drug that combines well with a drug scholar rock is testing out. https://seekingalpha.com/article/4825260?gt=f7616ae03966524e This situation thus places srrk in a place where we know it has value to multiple parties. At this stage approval or not this is going higher.
0 · Reply
Mookins
Mookins Oct. 1 at 1:23 PM
$FBIO Stop comparing $FBIO to $UNCY. $UNCY did a 1-for-10 reverse split right before its own vendor CRL, a combo that typically turbocharges downside. $FBIO has a significantly longer cash runway than $UNCY and screens closer to the $SRRK “fixable manufacturing hiccup” (the plant has already addressed the FDA’s September re-inspection) than $UNCY’s RS-amplified dump. Ultimately, we will see how the Market reacts today, but it's NOT the same situation as $UNCY
0 · Reply
Mookins
Mookins Oct. 1 at 12:44 PM
$FBIO For anyone wondering: remember, CUTX-101 had Priority Review (initial PDUFA June 30). So that doesn’t mean “6-12 months” for the do-over. The CRL was manufacturing (cGMP)-related, not clinical. The companies say the facility already sent responses after the FDA’s September re-inspection, and Sentynl will seek a post-CRL meeting to align the resubmission. That’s the right playbook. How long now? The clock restarts when they re-file the NDA. FDA then labels the resubmission: Class 1 ≈ 2 months Class 2 ≈ 6 months Manufacturing CRLs often land Class 2, but if fixes are minor and inspection boxes are checked. A couple of quick things to note: $SRRK just took a manufacturing-site CRL, and the stock rebounded once investors saw efficacy wasn’t questioned, different drug, similar optics. FBIO’s Urica benefits from Crystalys’ $205M financing (equity stake + 3% future royalties on dotinurad). should help the floor. A rally back up is possible, its worth keeping an eye on for sure.
0 · Reply
Mookins
Mookins Oct. 1 at 12:12 PM
$FBIO Similar to $SRRK last week, with no reason to doubt this is just a short delay, wonder if we see a rally back up.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 30 at 9:40 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SRRK Current Share Price: $38.31 Contracts: $SRRK January 15, 2027 $40 Calls Scale in: $9.40- $11.49 Scale out: $14.62-$18.80 Can Easily Capture: 60% ROI Blended DTE: 473 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 29 at 7:00 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SRRK Current Share Price: $38.75 Contracts: $SRRK January 15, 2027 $40 Calls Scale in: $7.22- $8.83 Scale out: $11.23-$14.45 Can Easily Capture: 60% ROI Blended DTE: 474 Days | Join Elites here: https://liquidtheta.com
0 · Reply
SweepCastApp
SweepCastApp Sep. 28 at 3:11 PM
$SRRK: Unusual Options Activity Alerted CALL flow observed 220x contracts at Strike price of $30 Exp on 10/17/2025 with Premium of $179K and showing BULLISH Sentiment
0 · Reply
PaulLaurent
PaulLaurent Sep. 28 at 2:57 PM
🌀 Weekly Swing Trades $CRNX – Exceeded profit zone, +26% from our entry. $DFLI – (swing-bot pick) Hit PT2 @ 0.5000, +29.5% from entry; cleared +20% from the entry zone en route. $QBTS – Missed projected profit zone by $0.20, but still +12% from the upper entry-zone price. $CLRB – Hit profit zone, +12% from the upper entry-zone price. $SRRK – Reached second target, +26% from our entry. Notes: Trim at PT1 (10–15%), move stops to breakeven, add only on clean VWAP/pivot reclaims. Winners were orderly; even the near-miss ($QBTS) paid with disciplined scaling.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Sep. 27 at 4:15 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SRRK Current Share Price: $36.46 Contracts: $SRRK January 21, 2028 $30 Calls Scale in: $13.41- $16.39 Scale out: $20.86-$26.82 Can Easily Capture: 60% ROI Blended DTE: 847 Days | Join Elites here: https://liquidtheta.com
0 · Reply
GoldenHarborPartners
GoldenHarborPartners Sep. 27 at 3:46 PM
$SRRK X/Stocktwits sentiment turning loud for SHOT — setup into Monday looks spicy.
0 · Reply
X_____
X_____ Sep. 26 at 9:01 PM
$SRRK $EA $PACS $MLTX $GPUS 🚀🚀💥 Load more ♥️..booming ♥️
0 · Reply
cheating_stock_investor
cheating_stock_investor Sep. 26 at 7:40 PM
$SRRK options activity on those 45's. Look interesting for a company with little following.
0 · Reply
Sillyspuh
Sillyspuh Sep. 26 at 7:28 PM
$SRRK Wow. Guess the CRL was a net positive. A drug that has no issues, and as soon as the Indiana site cleans things off, they are good to go. Anyone know a good cleaning company we can recommend?
1 · Reply